
WCLC 2024
Exhibitors
WCLC 2024 Exhibitors
The IASLC 2024 World Conference on Lung Cancer offers a tremendous opportunity to market to one of the largest international gatherings of researchers, clinicians, allied health professionals and patient advocates in the field of lung cancer and thoracic oncology. Over 7,000 clinicians and scientists from around the world are expected to attend. Increase your visibility and organization’s profile by becoming a Sponsor and/or Exhibitor or by holding an Industry Supported Symposium at this outstanding and important Conference.
Confirmed Exhibitors

American Association for Cancer Research (AACR)
Click Exhibitor Name to Read Bio

American Association for Cancer Research (AACR)

AbbVie
Click Exhibitor Name to Read Bio

AbbVie

Association of Cancer Care Centers (ACCC)
Click Exhibitor Name to Read Bio

Association of Cancer Care Centers (ACCC)

Akeso, Inc.
Click Exhibitor Name to Read Bio

Akeso, Inc.

ALCMI
Click Exhibitor Name to Read Bio

ALCMI

Amgen
Click Exhibitor Name to Read Bio

Amgen

Amoy Diagnostics Co., Ltd.
Click Exhibitor Name to Read Bio

Amoy Diagnostics Co., Ltd.

APSHO (Advanced Practitioner Society for Hematology and Oncology)
Click Exhibitor Name to Read Bio

APSHO (Advanced Practitioner Society for Hematology and Oncology)

AstraZeneca
Click Exhibitor Name to Read Bio

AstraZeneca

Bayer
Click Exhibitor Name to Read Bio

Bayer

Biocartis
Click Exhibitor Name to Read Bio

Biocartis

Biofidelity
Click Exhibitor Name to Read Bio

Biofidelity

BioNTech
Click Exhibitor Name to Read Bio

BioNTech

Boehringer Ingelheim
Click Exhibitor Name to Read Bio

Boehringer Ingelheim

Bristol Myers Squibb
Click Exhibitor Name to Read Bio

Bristol Myers Squibb

Burning Rock Dx
Click Exhibitor Name to Read Bio

Burning Rock Dx
We focus on providing multi-dimensional tumor genomic data solutions, multi-modal clinical trial solutions, integrated CDx development and commercialization, and precision patient recruitment for pharmaceutical companies, thereby efficiently facilitating the entire process of anti-cancer drug development.

Caris Life Sciences
Click Exhibitor Name to Read Bio

Caris Life Sciences

Catalyst Pharmaceuticals
Click Exhibitor Name to Read Bio

Catalyst Pharmaceuticals

CyPath Lung
Click Exhibitor Name to Read Bio

CyPath Lung

Daiichi Sankyo
Click Exhibitor Name to Read Bio

Daiichi Sankyo

DAVA Oncology
Click Exhibitor Name to Read Bio

DAVA Oncology

EMD Serono
Click Exhibitor Name to Read Bio

EMD Serono

Exact Sciences
Click Exhibitor Name to Read Bio

Exact Sciences

Flatiron Health
Click Exhibitor Name to Read Bio

Flatiron Health

Fosun Pharma USA
Click Exhibitor Name to Read Bio

Fosun Pharma USA

Foundation Medicine
Click Exhibitor Name to Read Bio

Foundation Medicine

Genentech
Click Exhibitor Name to Read Bio

Genentech

Genmab
Click Exhibitor Name to Read Bio

Genmab

Gilead Sciences
Click Exhibitor Name to Read Bio

Gilead Sciences

Global Lunch Cancer Coalition
Click Exhibitor Name to Read Bio

Global Lunch Cancer Coalition

GSK
Click Exhibitor Name to Read Bio

GSK

Guardant Health
Click Exhibitor Name to Read Bio

Guardant Health

Guangdong OptoMedic Technologies, Inc.
Click Exhibitor Name to Read Bio

Guangdong OptoMedic Technologies, Inc.

Jazz Pharmaceuticals
Click Exhibitor Name to Read Bio

Jazz Pharmaceuticals

Johnson & Johnson
Click Exhibitor Name to Read Bio

Johnson & Johnson

KRAS Kickers
Click Exhibitor Name to Read Bio

KRAS Kickers

LiveLung
Click Exhibitor Name to Read Bio

LiveLung

Lung Cancer Research Foundation (LCRF)
Click Exhibitor Name to Read Bio

Lung Cancer Research Foundation (LCRF)

Eli Lilly and Company
Click Exhibitor Name to Read Bio

Eli Lilly and Company

Median Technologies
Click Exhibitor Name to Read Bio

Median Technologies

Merck
Click Exhibitor Name to Read Bio

Merck

MeVis
Click Exhibitor Name to Read Bio

MeVis

Natera
Click Exhibitor Name to Read Bio

Natera
Identify High Risk Patients
Detect Recurrence Earlier
Monitor Immunotherapy Treatment Response
Learn more at www.natera.com/signatera-lungcancer-clinicians

Novartis
Click Exhibitor Name to Read Bio

Novartis
Reimagine medicine with us: Visit us at https://www.novartis.com/ and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.

Novocure
Click Exhibitor Name to Read Bio

Novocure
Headquartered in Root, Switzerland and with a growing global footprint, Novocure has regional operating centers in Portsmouth, New Hampshire and Tokyo, as well as a research center in Haifa, Israel.

Oncohost
Click Exhibitor Name to Read Bio

Oncohost

Oncology Advocates United for Climate and Health International
Click Exhibitor Name to Read Bio

Oncology Advocates United for Climate and Health International

Pfizer Oncology
Click Exhibitor Name to Read Bio

Pfizer Oncology

Predicine
Click Exhibitor Name to Read Bio

Predicine

Qure.ai
Click Exhibitor Name to Read Bio

Qure.ai

Regeneron
Click Exhibitor Name to Read Bio

Regeneron

Rigel Pharmaceuticals
Click Exhibitor Name to Read Bio

Rigel Pharmaceuticals

Scanlan International
Click Exhibitor Name to Read Bio

Scanlan International

Summit Therapeutics Inc.
Click Exhibitor Name to Read Bio

Summit Therapeutics Inc.

Takeda
Click Exhibitor Name to Read Bio

Takeda

Tempus
Click Exhibitor Name to Read Bio

Tempus

Thermo Fisher Scientific
Click Exhibitor Name to Read Bio

Thermo Fisher Scientific

The White Ribbon Project
Click Exhibitor Name to Read Bio

The White Ribbon Project

The 23andMe Lung Cancer Genetics Study
Click Exhibitor Name to Read Bio

The 23andMe Lung Cancer Genetics Study
Exhibit Hall Floorplan

Contact Us
For more information regarding promotion & advertising, symposium and exhibit opportunities, please contact:
International Association for the Study of Lung Cancer (IASLC)
Email: [email protected]
Phone: +1 720 598 1951
Fax: +1 720 325 2848